Analyst Consensus ?
ConsensusBuy50 ratings
Bullish3162.0%
Neutral1836.0%
Bearish12.0%
Lowe's Companies, Inc. · LOW · FY2026 Q1 · Calendar Q2 2026
Lowe's Q1 FY2026: Spring Demand and AI Tools Drive Modest Beat
Lowe's delivered a modest Q1 FY2026 beat, with revenue of $23.1B exceeding consensus by 0.4% and adjusted EPS of $3.03 topping estimates by 2.0%. Growth was led by the Pro segment, a 15.5% jump in online sales, and home services, all supported by strong spring seasonal execution. AI-powered tools -- Mylow and Mylow Companion -- are showing early traction, with conversion rates three times higher for AI-assisted shoppers. Management maintained full-year FY2026 guidance (sales $92-94B, comps flat to +2%, adjusted EPS $12.25-$12.75), signaling confidence in the Total Home strategy and acquisition integration despite an elevated-rate housing environment. The stock's muted reaction (+0.2% abnormal move on 2.3x baseline volume) suggests the market viewed the beat as incremental rather than transformative, with DIY demand recovery and FBM/ADG integration remaining the key swing factors.
Reported Before market openNYSEConsumer Cyclical
$118.55B market cap
100quality score
Company context
Snapshot as of publicationLowe's Companies, Inc., together with its various subsidiary entities, operates as a prominent home improvement retailer serving both the United States and international markets. The company supplies a broad spectrum of items essential for construction, upkeep, renovations, and interior design projects. Its comprehensive product line encompasses major appliances, seasonal and outdoor living essentials, lawn and garden tools, timber, kitchen and bathroom fixtures, power tools, paints, custom millwork, general hardware, flooring options, plumbing components, building materials, decorative accents, lighting solutions, and electrical supplies.…
Earnings scorecard
Reported versus consensus
Reported EPS
$3.03
Consensus $3
EPS surprise
+2.0%
Reported versus consensus
Reported revenue
$23.08B
Consensus $22.98B
Revenue surprise
+0.4%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$215.64Current
$210Low
$263.4Average
$325High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Aug 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Aug 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 13, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 12, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 11, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| UBS | Buy | Buy | Maintain | May 21, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 21, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | May 21, 2026 |
| TD Cowen | Hold | Hold | Maintain | May 21, 2026 |
| Keybanc | Overweight | Overweight | Maintain | May 21, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | May 21, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 21, 2026 |
| Baird | Outperform | Outperform | Maintain | May 21, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | May 21, 2026 |
| Stifel | Hold | Hold | Maintain | May 18, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 18, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 14, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Feb 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 15, 2026 |
| Gordon Haskett | Buy | Hold | Upgrade | Jan 13, 2026 |
| Barclays | Overweight | Equal Weight | Upgrade | Jan 7, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 21, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Dec 12, 2024 |
| Loop Capital | Buy | Hold | Upgrade | Oct 9, 2024 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Apr 2, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 12, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Oct 19, 2022 |
| R5 Capital | Hold | Buy | Downgrade | Oct 10, 2022 |
| Jefferies | Buy | Buy | Maintain | Oct 3, 2022 |
| MKM Partners | Neutral | Neutral | Maintain | Aug 18, 2022 |
| OTR Global | Mixed | Positive | Downgrade | May 10, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 19, 2021 |
| Zelman | Hold | Buy | Downgrade | Apr 15, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Apr 14, 2021 |
| Nomura Instinet | Buy | Buy | Maintain | Jun 23, 2020 |
| Nomura | Buy | Buy | Maintain | Jun 23, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 21, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 27, 2020 |
| Piper Jaffray | Overweight | Neutral | Upgrade | Oct 15, 2019 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 8, 2019 |
| Citi | Buy | Buy | Maintain | Sep 13, 2019 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 21, 2018 |
| Bank of America | Buy | Buy | Maintain | Aug 23, 2018 |
| Argus | Buy | Buy | Maintain | May 25, 2018 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 2, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 1, 2018 |
| Cleveland Research | Neutral | Buy | Downgrade | Oct 6, 2016 |
| Canaccord Genuity | Hold | Sell | Upgrade | Nov 19, 2014 |
| ISI Group | Buy | Neutral | Upgrade | May 8, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $215.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Scot Ciccarelli | $255 | $215.84 | +18.3% | May 21, 2026 |
| RBC Capital | Analyst unavailable | $232 | $216.57 | +7.6% | May 21, 2026 |
| Piper Sandler | Peter Keith | $276 | $215.96 | +28.0% | May 21, 2026 |
| Wolfe Research | Analyst unavailable | $254 | $221.1 | +17.8% | May 21, 2026 |
| Wells Fargo | Zachary Fadem | $255 | $221.1 | +18.3% | May 21, 2026 |
| Truist Financial | Scot Ciccarelli | $280 | $217.45 | +29.8% | May 20, 2026 |
| D.A. Davidson | Michael Baker | $275 | $262.54 | +27.5% | Feb 26, 2026 |
| Jefferies | Jonathan Matuszewski | $305 | $263.02 | +41.4% | Feb 25, 2026 |
| RBC Capital | Steven Shemesh | $257 | $277.09 | +19.2% | Feb 23, 2026 |
| Bernstein | Analyst unavailable | $313 | $281.16 | +45.1% | Feb 18, 2026 |
| Truist Financial | Analyst unavailable | $295 | $277.01 | +36.8% | Jan 16, 2026 |
| Morgan Stanley | Simeon Gutman | $296 | $274.95 | +37.3% | Jan 15, 2026 |
| Gordon Haskett Capital Corporation | Analyst unavailable | $325 | $270.89 | +50.7% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $285 | $246.49 | +32.2% | Jan 7, 2026 |
| Truist Financial | Scot Ciccarelli | $269 | $248.82 | +24.7% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $252 | $229.37 | +16.9% | Nov 20, 2025 |
| D.A. Davidson | Michael Baker | $250 | $230.48 | +15.9% | Nov 20, 2025 |
| Robert W. Baird | Peter Benedict | $290 | $230.48 | +34.5% | Nov 20, 2025 |
| UBS | Analyst unavailable | $316 | $230.48 | +46.5% | Nov 20, 2025 |
| Mizuho Securities | Analyst unavailable | $272 | $230.48 | +26.1% | Nov 20, 2025 |
| Bernstein | Zhihan Ma | $284 | $230.48 | +31.7% | Nov 20, 2025 |
| Stifel Nicolaus | Andrew Carter | $230 | $228.09 | +6.7% | Nov 14, 2025 |
| Wolfe Research | Analyst unavailable | $308 | $267.95 | +42.8% | Sep 17, 2025 |
| Mizuho Securities | David Bellinger | $285 | $257.54 | +32.2% | Aug 29, 2025 |
| Barclays | Analyst unavailable | $267 | $255.65 | +23.8% | Aug 21, 2025 |
| Truist Financial | Scot Ciccarelli | $264 | $223.75 | +22.4% | May 22, 2025 |
| Mizuho Securities | David Bellinger | $280 | $223.75 | +29.8% | May 22, 2025 |
| Bernstein | Zhihan Ma | $266 | $223.75 | +23.4% | May 22, 2025 |
| Piper Sandler | Peter Keith | $269 | $232.89 | +24.7% | Mar 24, 2025 |
| Jefferies | Jonathan Matuszewski | $301 | $235.83 | +39.6% | Nov 19, 2024 |
| Stifel Nicolaus | Andrew Carter | $265 | $235.83 | +22.9% | Nov 19, 2024 |
| Truist Financial | Scot Ciccarelli | $310 | $235.83 | +43.8% | Nov 19, 2024 |
| Goldman Sachs | Kate McShane | $260 | $235.83 | +20.6% | Nov 19, 2024 |
| Stifel Nicolaus | Andrew Carter | $260 | $268.13 | +20.6% | Nov 11, 2024 |
| Telsey Advisory | Joseph Feldman | $305 | $269.18 | +41.4% | Nov 8, 2024 |
| Loop Capital Markets | Laura Champine | $300 | $273.27 | +39.1% | Oct 9, 2024 |
| Loop Capital Markets | Laura Champine | $250 | $272.64 | +15.9% | Oct 2, 2024 |
| Oppenheimer | Brian Nagel | $305 | $262.29 | +41.4% | Sep 24, 2024 |
| Piper Sandler | Peter Keith | $262 | $242.44 | +21.5% | Aug 21, 2024 |
| Guggenheim | Steven Forbes | $260 | $240.33 | +20.6% | Aug 21, 2024 |
| Robert W. Baird | Peter Benedict | $265 | $241.7 | +22.9% | Aug 21, 2024 |
| Bank of America Securities | Robert Ohmes | $275 | $240.33 | +27.5% | Aug 21, 2024 |
| J.P. Morgan | Christopher Horvers | $272 | $243.21 | +26.1% | Aug 20, 2024 |
| Telsey Advisory | Joseph Feldman | $230 | $222.48 | +6.7% | May 22, 2024 |
| Truist Financial | Scot Ciccarelli | $265 | $224.86 | +22.9% | May 22, 2024 |
| Piper Sandler | Peter Keith | $264 | $222.42 | +22.4% | May 22, 2024 |
| RBC Capital | Steven Shemesh | $246 | $222.79 | +14.1% | May 22, 2024 |
| UBS | Michael Lasser | $270 | $224.86 | +25.2% | May 22, 2024 |
| Barclays | Matthew McClintock | $229 | $224.86 | +6.2% | May 22, 2024 |
| Wells Fargo | Zachary Fadem | $290 | $224.86 | +34.5% | May 22, 2024 |
| Evercore ISI | Greg Melich | $250 | $224.86 | +15.9% | May 22, 2024 |
| Stifel Nicolaus | Andrew Carter | $250 | $224.86 | +15.9% | May 21, 2024 |
| Jefferies | Jonathan Matuszewski | $267 | $229.17 | +23.8% | May 21, 2024 |
| Loop Capital Markets | Laura Champine | $230 | $238.01 | +6.7% | Apr 5, 2024 |
| D.A. Davidson | Michael Baker | $270 | $251.42 | +25.2% | Mar 27, 2024 |
| RBC Capital | Steven Shemesh | $194 | $194.58 | -10.0% | Nov 7, 2023 |
| Stifel Nicolaus | John Baugh | $270 | $210.13 | +25.2% | Sep 22, 2023 |
| Bernstein | Dean Rosenblum | $282 | $232.51 | +30.8% | Sep 5, 2023 |
| Telsey Advisory | Joseph Feldman | $225 | $207.22 | +4.3% | May 17, 2023 |
| Barclays | Analyst unavailable | $215 | $214.73 | -0.3% | Feb 8, 2023 |
| UBS | Analyst unavailable | $250 | $197.05 | +15.9% | Jan 6, 2023 |
| Credit Suisse | Analyst unavailable | $210 | $203.17 | -2.6% | Dec 20, 2022 |
| Goldman Sachs | Kate McShane | $246 | $206.89 | +14.1% | Dec 7, 2022 |
| Bernstein | Analyst unavailable | $237 | $206.18 | +9.9% | Dec 6, 2022 |
| Telsey Advisory | Telsey Advisory Telsey Advisory | $255 | $210.27 | +18.3% | Nov 21, 2022 |
| Goldman Sachs | Analyst unavailable | $241 | $215.13 | +11.8% | Nov 17, 2022 |
| Wells Fargo | Zachary Fadem | $245 | $214.86 | +13.6% | Nov 16, 2022 |
| Jefferies | Analyst unavailable | $259 | $194.85 | +20.1% | Oct 3, 2022 |
| MKM Partners | Analyst unavailable | $220 | $216.52 | +2.0% | Aug 18, 2022 |
| Wedbush | Analyst unavailable | $225 | $216.52 | +4.3% | Aug 18, 2022 |
| Truist Financial | Analyst unavailable | $263 | $215.24 | +22.0% | Aug 18, 2022 |
| Robert W. Baird | Analyst unavailable | $235 | $215.55 | +9.0% | Aug 18, 2022 |
| Goldman Sachs | Analyst unavailable | $252 | $214.87 | +16.9% | Aug 18, 2022 |
| J.P. Morgan | Analyst unavailable | $210 | $194.45 | -2.6% | Aug 9, 2022 |
| Wells Fargo | Analyst unavailable | $220 | $187.95 | +2.0% | Aug 3, 2022 |
| Morgan Stanley | Analyst unavailable | $270 | $189.9 | +25.2% | Jul 20, 2022 |
| Wells Fargo | Zachary Fadem | $240 | $172.47 | +11.3% | Jun 18, 2022 |
| D.A. Davidson | Analyst unavailable | $240 | $189.32 | +11.3% | May 19, 2022 |
| Truist Financial | Analyst unavailable | $237 | $187.94 | +9.9% | May 19, 2022 |
| Wedbush | Analyst unavailable | $200 | $191.62 | -7.3% | May 19, 2022 |
| Jefferies | Analyst unavailable | $238 | $187.65 | +10.4% | May 19, 2022 |
| Citigroup | Steven Zaccone | $222 | $184.83 | +2.9% | May 18, 2022 |
| Telsey Advisory | Joseph Feldman | $250 | $183.82 | +15.9% | May 18, 2022 |
| Wells Fargo | Zachary Fadem | $260 | $206.66 | +20.6% | Apr 10, 2022 |
| Gordon Haskett Capital Corporation | Chuck Grom | $255 | $202.4 | +18.3% | Apr 3, 2022 |
| Robert W. Baird | Peter Benedict | $285 | $225.02 | +32.2% | Jan 23, 2022 |
| Morgan Stanley | Simeon Gutman | $280 | $238.41 | +29.8% | Jan 18, 2022 |
| Citigroup | Steven Zaccone | $292 | $238.41 | +35.4% | Jan 18, 2022 |
| Truist Financial | Scot Ciccarelli | $293 | $249.9 | +35.9% | Jan 12, 2022 |
| D.A. Davidson | Michael Baker | $292 | $255.55 | +35.4% | Dec 30, 2021 |
| Guggenheim | Steven Forbes | $300 | $252.41 | +39.1% | Dec 16, 2021 |
| Oppenheimer | Brian Nagel | $300 | $250.35 | +39.1% | Dec 6, 2021 |
| Goldman Sachs | Kate McShane | $278 | $246.57 | +28.9% | Nov 18, 2021 |
| Loop Capital Markets | Laura Champine | $240 | $246.57 | +11.3% | Nov 18, 2021 |
| Barclays | Karen Short | $280 | $246.57 | +29.8% | Nov 18, 2021 |
| UBS | Michael Lasser | $290 | $246.57 | +34.5% | Nov 18, 2021 |
| Credit Suisse | Lavesh Hemnani | $220 | $201.2 | +2.0% | Aug 19, 2021 |
| Atlantic Equities | Sam Hudson | $240 | $198.72 | +11.3% | Apr 14, 2021 |
Track every rating change on LOW the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
+1.2%
Event window
SPY move
+1.0%
Same window
Abnormal move
+0.2%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
+0.5%
Up to 20 sessions
LOWSPY benchmark
Follow LOW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Versus the prior quarter (Q4 FY2025), several positive shifts emerged. Online growth accelerated to 15.5% in Q1, AI tools demonstrated measurable conversion lift (3x for Mylow users), and the company launched HomeCare+, a new subscription maintenance service exclusive to MyLowe's Rewards members. The Pro segment continued to outperform DIY, extending a trend noted in Q4. New initiatives include a $250M Lowe's Foundation investment to train 250,000 skilled-trade workers and a Lionel Messi summer marketing partnership, building on the prior quarter's MrBeast activation. Capex outlook shifted from stable to increasing. However, guidance was reaffirmed rather than raised, and the core housing headwinds -- high mortgage rates and low turnover -- remain unchanged.
Guidance delta
FY2026 guidance was maintained at the levels introduced in Q4 FY2025: total sales of $92-94B, comparable sales flat to +2%, adjusted EPS of $12.25-$12.75, and adjusted operating margin of 11.6-11.8%. Management did not raise guidance despite the Q1 beat, preserving cushion for macro uncertainty and acquisition integration costs.
Key takeaways
- Q1 FY2026 revenue of $23.1B beat estimates by 0.4%; adjusted EPS of $3.03 beat by 2.0%
- Comparable sales rose 0.6%, driven by strong spring execution across Pro, appliances, and online channels
- Online sales grew 15.5%, aided by AI tools and free same-day delivery
- Mylow AI assistant users convert at 3x the rate of non-users, showing early ROI on AI investment
- Pro segment outperformed DIY, supported by MyLowe's Pro Rewards and extended aisle initiatives
- FBM and ADG acquisitions are progressing, with cost synergies and cross-selling opportunities on track
Management priorities
- Scale HomeCare+ subscription to drive recurring revenue
- Complete national rollout of workwear and pet private-brand assortments
- Expand AI capabilities into demand planning, pricing, and replenishment
- Continue seasonal promotional calendar (Memorial Day, Father's Day, July 4th)
- Leverage Lionel Messi partnership for summer marketing
- Advance FBM and ADG integration to capture new-home construction opportunities
Related earnings events
Consumer CyclicalSources
- Earnings call transcript and parsed analysis · 2026-05-20T19:22:51.341553+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T00:24:05.385834+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T00:24:05.383326+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.